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CLINICAL CARE CONUNDRUMS
‘‘Different Strokes for Different Folks’’
The approach to clinical conundrums by an expert clinician is revealed through the presentation of an actual patient’s case in an
approach typical of a morning report. Similarly to patient care, sequential pieces of information are provided to the clinician, who is
unfamiliar with the case. The focus is on the thought processes of both the clinical team caring for the patient and the discussant.
This icon represents the patient’s case. Each paragraph that follows represents the discussant’s thoughts.
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A 35-year-old woman presented to her primary care phy-
sician complaining of left post-auricular pain, swelling,
and redness. She described the pain as 8 out of 10, constant,
sharp, and nonradiating. She denied fever or chills. A presump-
tive diagnosis of cellulitis led to a prescription for oral trimetho-
prim-sulfamethoxazole. Left facial swelling worsened despite 4
days of antibiotics, so she came to the emergency department.
Noninfectious causes of this woman’s symptoms include
trauma, or an inﬂammatory condition such as polychondritis.
Key infectious considerations are mastoiditis or a mastoid ab-
scess. Herpes zoster with involvement of the pinna and audi-
tory canal may also present with pain and redness. In the ab-
sence of ﬁndings suggestive of an infection arising from the
auditory canal, cellulitis is a reasonable consideration. With
the growing incidence of community-acquired methicillin-re-
sistant Staphylococcus aureus infections, an agent effective
against this pathogen such as trimethoprim-sulfamethoxazole
may be used, usually in combination with an antibiotic that
provides more reliable coverage for group A streptococcus.
Her past medical history included poorly controlled type
II diabetes mellitus and asthma. She reported no previous
surgical history. Her current medications were insulin, albuterol
inhaler, and trimethoprim-sulfamethoxazole, although she had
a history of noncompliance with her insulin. She was married
with 1 child and was unemployed. She smoked 1 pack of ciga-
rettes daily, drank up to 6 beers daily, and denied use of illicit
drugs.
Her history of diabetes increases her risk of malignant otitis
externa. Both diabetes and excess alcohol consumption are
risk factors for herpes zoster. Smoking has been shown to
increase the risk of otitis media and carriage by S. pneumo-
niae, a common pathogen in ear infections.
She was ill-appearing and in moderate respiratory distress.
Her temperature was 39C, blood pressure 149/93 mmHg,
pulse 95 beats per minute, respiratory rate of 26 times per minute,
with an oxygen saturation of 96% while breathing ambient air.
She had swelling of the left side of the face extending to the left
forehead and lateral neck. Examination of the external ear and
auditory canal were unremarkable. The swelling had no asso-
ciated erythema, tenderness, or lymphadenopathy. She had no
oropharyngeal or nasal ulcers present. Her pupils were equal,
round, and reactive to light and accommodation with normal
sclera. Her trachea was midline; thyroid exam was normal. The
heart sounds included normal S1 and S2 without murmurs,
rubs, or gallops. Her lung exam was remarkable for inspiratory
stridor. The abdominal examination revealed no distention,
tenderness, organomegaly, or masses. Cranial nerve testing
revealed a left-sided central seventh nerve palsy along with
decreased visual acuity of the left eye. Strength, sensation, and
deep tendon reﬂexes were normal.
While there are many causes of facial nerve palsy, distinguish-
ing between a peripheral palsy (which causes paralysis of the
entire ipsilateral side of the face) and a central palsy (which
spares the musculature of the forehead) is important. The
most common type of peripheral facial nerve palsy is Bell’s
palsy. Infections such as meningitis or tumors of the central
nervous system can cause central facial nerve or other cranial
nerve palsy. Important infections to consider in this case
would be viral such as herpes zoster or simplex, or atypical
bacteria such as Mycoplasma and Rickettsia, which may
explain the neurologic but not all of the other clinical ﬁndings
in this case. It is also critical to determine whether she has an
isolated seventh cranial nerve palsy or if other cranial nerves
are involved such as may occur with basilar meningitis, which
has a myriad of infectious and noninfectious causes. The
decreased visual acuity may be a result of corneal dryness and
abrasions from inability to close the eye but may also repre-
sent optic nerve problems, so detailed ophthalmologic exam
is essential. Her ill appearance coupled with facial and neck
swelling leads me to at least consider Lemierre’s syndrome
with central nervous system involvement. Finally, facial swel-
ling and the inspiratory stridor may represent angioedema,
although one-sided involvement of the face would be unusual.
The results of initial laboratory testing were as follows:
sodium, 138 mmol/L; potassium, 3.4 mmol/L; chloride,
109 mmol/L; bicarbonate, 14 mmol/L; blood urea nitrogen
level, 19 mg/dL; creatinine, 1.1 mg/dL; white cell count,
23,510/mm3; differential, 90% neutrophils, 1% bands, 7%
lymphocytes, 2% monocytes; hemoglobin level, 12.5 g/dL;
platelet count, 566,000/mm3; hemoglobin A1c, 11%; albu-
min, 1.6 g/dL; total protein, 6.2 g/dL; total bilirubin, 0.8 mg/
dL; alkaline phosphatase, 103 U/L; alanine aminotransferase
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level, 14 U/L; international normalized ratio of 1.2; partial
thromboplastin time, 29 seconds (normal value, 24–34 sec-
onds); erythrocyte sedimentation rate, 121 mm/hr; creatine
kinase, 561 U/L (normal value 25–190). Arterial blood gas
measurements with the patient breathing 50% oxygen
revealed a pH of 7.34, a partial pressure of carbon dioxide of
28 mmHg, and a partial pressure of oxygen of 228 mmHg.
I am concerned that this patient has sepsis, likely due to an in-
fectious trigger. With her clinical presentation localized to the
head and neck, her history of diabetes, and the accelerated
sedimentation rate, malignant otitis externa would explain
many of her ﬁndings. Empiric anti-infective therapy directed
toward Pseudomonas aeruginosa should be initiated, and
imaging of the head and ear should be undertaken.
The patient required intubation due to increased respira-
tory distress and stridor. Her physicians used intrave-
nous vancomycin, clindamycin, and piperacillin/tazobactam
to treat presumed cellulitis. Her abnormal neurologic exam
led to magnetic resonance (MR) imaging and MR angiogra-
phy of her neck and brain, which showed evidence of multiple
regions of ischemia in the left occipital and inferior parietal
distributions, as well as bilateral cerebellar distributions and
enhancement of the parotid gland and mastoid air cells (Fig-
ure 1). A cerebral angiogram revealed irregularity and caliber
reduction in multiple cervical and intracranial arteries, associ-
ated with intraluminal thrombi within the left intracranial
vertebral artery, consistent with either vasculitis or infectious
angioinvasion (Figure 2).
The angioinvasive nature of the ﬁndings on imaging leads me
to suspect fungal infection. The patient’s history of diabetes
mellitus and acidosis are risk factors for mucormycosis. As-
pergillus and Fusarium may also be angioinvasive but would
be much more likely in neutropenic or severely immunocom-
promised patients. S. aureus may cause septic emboli mimick-
ing angioinvasion but should be readily detected in conven-
tional blood cultures. At this point, I would empirically begin
amphotericin B; tissue, however, is needed for deﬁnitive diag-
nosis and a surgical consult should be requested.
After reviewing her imaging studies, an investigation for
vasculitis and hypercoagulable states including antinu-
clear antibody, anti-deoxyribonucleic acid, anti-Smith anti-
body, anti-SSA antibody level, anti-SSB level, antineutrophil
cytoplasmic antibody, activated protein C resistance level,
factor VIII level, human immunodeﬁciency virus antibody,
homocysteine level, cardiolipin antibody testing, lupus antico-
agulant, prothrombin 20210 mutation, and protein C level
was done, and all tests were normal. Protein S level was
slightly low at 64% (normal value 65%–140%). Given the
enlarged parotid gland and the enhancement of the left pa-
rotid bed on magnetic resonance imaging, she underwent a
parotid biopsy that revealed sialadenitis.
Systemic vasculitides can result in tissue damage, mediated by
the release of endogenous cellular contents from dying cells,
known as damage-associated molecular patterns, sufﬁcient to
cause systemic inﬂammatory response syndrome (SIRS). This
patient presented with acute symptoms but has negative labo-
ratory studies for autoantibodies. The parotid biopsy also did
not reveal evidence of vasculitis. All these ﬁndings make the
diagnosis of vasculitis much less likely.
She remained in the medical intensive care unit on me-
chanical ventilation, with minimal symptomatic
improvement. On hospital day 10, the patient developed ne-
crosis of the left external ear. A punch biopsy of the necrotic
area of her left pinna was performed; the pathology report
read: ‘‘Sections of punch biopsy of skin show an unremark-
able epidermis. There is dermal necrosis involving the stroma
and adnexal structures. Intravascular thrombi within the deep
dermis are seen. Within superﬁcial dermis there are broad,
elongated, nonseptated hyaline structures reminiscent of
Mucor. Special stains (periodic acid-Schiff stain and Grocott
Gomori methenamine silver stain [GMS]) performed with
appropriately reactive controls fail to highlight these struc-
tures’’ (Figure 3). The infectious disease team reviewed the
pathology slides with the pathologist. As there was inconclu-
sive evidence for zygomycosis, ie, only a few hyaline struc-
tures which failed to stain with GMS stain, the consultants
recommended no change in the patient’s management.
FIG. 1. Magnetic resonance imaging (MRI) showing enlargement and
enhancement of the left parotid gland (arrow).
FIG. 2. Cerebral angiogram showing multiple areas of vessel irregularity
(arrows) in the left internal carotid artery.
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The gross and microscopic evidence of necrosis and areas of
intravascular thrombi are nonspeciﬁc but compatible with a
fungal infection in a patient with risk factors for zygomycosis.
The GMS stain is a very sensitive stain for fungal structures,
so a negative stain in this case is surprising, but additional
testing such as immunohistochemistry should be pursued to
conﬁrm or refute this diagnosis. While Rhizopus species can
be contaminants, the laboratory ﬁnding of these organisms in
specimens from patients with risk factors for zygomycosis
should not be ignored.
On hospital day 12, the patient was noted to have
increased facial swelling. A computed tomographic (CT)
angiogram of the neck revealed necrosis of the anterior and
posterior paraspinal muscles from the skull base to C3–4,
marked swelling of the left parotid gland, and left inferior pari-
eto-occipital enhancing lesion. An incisional parotid biopsy
was performed. Special stains were positive for broad-based
fungal hyphae consistent with mucormycosis (Figure 4).
Given these ﬁndings, the patient should be started on ampho-
tericin B immediately. Medical therapy alone generally
does not sufﬁce, and aggressive surgical debridement com-
bined with intravenous antifungal therapy results in better
outcomes. The longer the duration of symptoms and the
greater the progression of disease, the less favorable the
prognosis.
The patient was started on amphotericin B lipid complex
and micafungin. However, after 16 days of therapy,
repeat imaging of the neck showed worsening necrosis of the
neck muscles. At this time, she underwent extensive debride-
ment of face and neck, and posaconazole was added. After
prolonged hospitalization, she was discharged to a rehabilita-
tion facility on posaconazole. She resided in a nursing facility
for 6 months. One year after her hospitalization, she is living
at home and is able to ambulate independently, but requires
feeding through a percutaneous endoscopic gastrostomy
(PEG) tube because she remains dysphagic.
COMMENTARY
Infections caused by the ubiquitous fungi of the class Zygo-
mycetes typically take 1 of 5 forms: rhinocerebral, pulmo-
nary, gastrointestinal, disseminated, and cutaneous. The pre-
sentation varies widely, ranging from plaques, skin swelling,
pustules, cellulitis, blisters, nodules, ulcerations, and ecthyma
gangrenosum-like lesions to deeper infections such as necrot-
izing fasciitis, osteomyelitis, and disseminated infection.1
Infections typically occur in immunocompromised hosts,
including transplant recipients and patients with hematologic
malignancy, but also occur in patients with diabetes mellitus,
intravenous drug users, and patients on deferoxamine ther-
apy.2 Deferoxamine and other iron-binding therapy is
thought to predispose to zygomycetes infections because of
improved iron uptake of the fungal species and, thus, stimula-
tion of growth.3 Pulmonary and rhinocerebral infections are
the most common clinically encountered forms, and 44% of
cutaneous infections are complicated by deep extension or
dissemination.4
The articles cited above describe the more typical presenta-
tions of this rare disease. However, this patient had an un-
usual presentation, as parotid involvement due to zygomyco-
sis has only been described once previously.5 Her
inﬂammatory vasculitis and ensuing strokes from involvement
of the carotid artery are recognized complications of zygomy-
cosis, and in 1 case series of 41 patients with rhinocerebral
mucormycosis, carotid involvement was seen in 31% of
patients.6 After the punch biopsy of the patient’s pinna show-
ing nonseptated hyphae ‘‘reminiscent’’ of Mucor, why did her
physicians delay administering amphotericin?
There are 2 likely possibilities: anchoring bias or error in
medical decision-making due to inaccurate probability esti-
mates. Anchoring bias describes a heuristic where the initial
diagnosis or gestalt biases the physician’s process for assign-
ing a ﬁnal diagnosis.7,8 This bias creates cognitive errors by
limiting creativity in diagnosis. In this case, the infectious dis-
ease team carefully weighed the information obtained from
the ﬁrst biopsy. Given their low pretest estimate of this virtu-
ally unreported presentation of a rare disease, they decided to
evaluate further without beginning antifungal therapy. Of
note, there were few hyaline structures, and those structures
lacked uptake of GMS. Since they considered the diagnosis
yet rejected the diagnosis due to insufﬁcient evidence, it is
unlikely that anchoring bias played a role.
Was there an error in medical decision-making? The physi-
cians in this case faced a very common medical dilemma:
whether or not to start a toxic medication empirically or wait
for diagnostic conﬁrmation prior to treatment.9 To solve this
dilemma, one can apply decision analysis. Moskowitz et al
FIG. 3. Punch biopsy of the patient’s left external ear showing broad
elongated, nonseptated hyaline structures which failed to stain with Grocott
Gomori methenamine silver stain (GMS) (arrows).
FIG. 4. Parotid tail excisional biopsy with broad fungal hyphae (arrows).
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described 5 phases of medical decision analysis by which a
probabilistic ‘‘right’’ answer to clinical scenarios can be
deduced mathematically.10 To solve this problem, probabil-
ities must be assigned to the risk of giving a drug to a patient
without the disease versus the risk of not giving a drug to a
patient with the disease. For example, amphotericin deoxy-
cholate causes acute renal failure in 30% to 47% of patients.
Newer formulations of amphotericin, such as liposomal
amphotericin and lipid complex, result in lower rates of neph-
rotoxicity (27% vs 47%). The risk of not giving amphotericin
to a patient with zygomycosis is death. Even in patients
treated with amphotericin, the mortality rate has been shown
to be 66%, and up to 100% in those with strokes related to
zygomycosis.2,6,11 Simply looking at these probabilities, deci-
sion analysis would favor empiric treatment.
The physicians caring for this patient did not have the
luxury of retrospective speculation. After looking at all of the
data, the equivocal skin biopsy and rare clinical presentation,
the question to ask would change: What is the risk of giving
amphotericin empirically to someone who, based on available
information, has a very low probability of having zygomyco-
sis? When phrased in this manner, there is a 47% chance of
nephrotoxicity with amphotericin versus the very small prob-
ability that you have diagnosed a case of zygomycosis that
has only been described once in the literature. Mathematically
and—more importantly—clinically, this question becomes
more difﬁcult to answer. However, no value can be placed on
the possibility of death in suspected zygomycosis, and the risk
of short-term amphotericin use is much less than that of a
course of treatment. As such, empiric therapy should always
be given.
Physicians are not mathematicians, and dynamic clinical
scenarios are not so easily made into static math problems.
Disease presentations evolve over time towards a diagnos-
able clinical pattern, as was the case with this patient. Two
days after the aforementioned biopsy, she worsened and in
less time than it would have taken to isolate zygomycosis
from the ﬁrst biopsy, a second biopsy revealed the typical
nonseptated hyphae demarcated with the GMS stain. Even
appropriate diagnostic testing, thoughtful interpretation,
and avoidance of certain cognitive errors can result in
incorrect diagnoses and delayed treatment. It is monitoring
the progression of disease and collecting additional data
that allows physicians to mold a diagnosis and create a
treatment plan.
The primary treatment of zygomycosis should include
amphotericin. However, there are limited data to support
combination therapy with an echinocandin in severe cases,
as in this patient.12 Posaconazole is not recommended for
monotherapy as an initial therapy, but there is data for its
use as salvage therapy in zygomycosis.13 This case high-
lights the difﬁculties that physicians face in the diagnosis
and treatment of rare diseases. Cerebral infarction in a he-
matologic malignancy, uncontrolled diabetes, or iron chela-
tion therapy could be the initial presentation of rhinocere-
bral zygomycosis. There truly are different strokes for
different folks. Recognizing this and similar presentations
may lead to a more rapid diagnosis and treatment of
zygomycosis.
TEACHING POINTS
1. Zygomycosis has a wide range of clinical presentations
ranging from skin lesions to deep tissue infections. As it is
an angioinvasive organism, it can also present as cerebral
infarcts and brain abscesses.
2. Zygomycosis infections should be suspected in patients
with uncontrolled diabetes, hematologic or oncologic
malignancies, and patients on iron chelation therapy with
a potentially compatible clinical picture.
3. If zygomycosis infection is suspected, rapid histologic diag-
nosis should be attempted. However, as histologic diagno-
sis can take time, empiric therapy with amphotericin
should always be administered.
4. Amphotericin remains the primary medical therapy for this
disease; however, there is limited emerging evidence to sug-
gest that echinocandins can be used in combination with
amphotericin for improved treatment of severe rhinocere-
bral zygomyocosis. Posaconazole has a role as salvage ther-
apy in zygomycosis, but should not be used as the sole
primary treatment.
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